No recent analyst price targets found for BRSYF.
Latest News for BRSYF
BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives
BURLINGTON, Mass. and JERUSALEM, June 22, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S. providing favorable coverage for its SWIFT™ Accelerated Deep TMS™ protocol. The announcement comes after a series of favorable…
BrainsWay Ltd. (BWAY) Q1 2026 Earnings Call Transcript
BrainsWay Ltd. (BWAY) Q1 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BRSYF.
Senate Trading
No Senate trades found for BRSYF.
U.S. House Trading
No House trades found for BRSYF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.